Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme

British Journal of Cancer

Volumn 101, Issue 8, 2009, Pages 1274-1281

  Van Rossum, L G M ^a   Van Rijn, A F ^b   Laheij, R J F ^a   Van Oijen, M G H ^a   Fockens, P ^b   Jansen, J B M J ^a   Verbeek, A L M ^a   Dekker, E ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Colonoscopy; Colorectal cancer; Epidemiology; Faecal occult blood test; Screening

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSOR; TUMOR LOCALIZATION;

AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOCHEMISTRY; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD;

EID: 70349952524     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605326     Document Type: Article

References (24)

1. Betes M, Munoz-Navas MA, Duque JM, Angos R, Macias E, Subtil JC, Herraiz M, De La Riva S, Delgado-Rodriguez M, Martinez-Gonzalez MA (2003) Use of colonoscopy as a primary screening test for colorectal cancer in average risk people. Am J Gastroenterol 98: 2648-2654
2. Brecht JG, Robra BP (1987) A graphic method of estimating the specificity of screening programmes from incomplete follow-up data. Methods Inf Med 26: 53-58
3. Castiglione G, Grazzini G, Miccinesi G, Rubeca T, Sani C, Turco P, Zappa M (2002) Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood. J Med Screen 9: 99-103
4. Chiang CH, Jeng JE, Wang WM, Jheng BH, Hsu WT, Chen BH (2006) A comparative study of three fecal occult blood tests in upper gastrointestinal bleeding. Kaohsiung J Med Sci 22: 223-228
5. Faivre J, Dancourt V, Lejeune C, Tazi MA, Lamour J, Gerard D, Dassonville F, Bonithon-Kopp C (2004) Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastro-enterology 126: 1674-1680 (Pubitemid 38736331)
6. Fenocchi E, Martinez L, Tolve J, Montano D, Rondan M, Parra-Blanco A, Eishi Y (2006) Screening for colorectal cancer in Uruguay with an immunochemical faecal occult blood test. Eur J Cancer Prev 15: 384-390
7. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18: 581-592 (Pubitemid 46359643)
8. Grazzini G, Castiglione G, Ciabattoni C, Franceschini F, Giorgi D, Gozzi S, Mantellini P, Lopane P, Perco M, Rubeca T, Salvadori P, Visioli CB, Zappa M (2004) Colorectal cancer screening programme by faecal occult blood test in Tuscany: first round results. Eur J Cancer Prev 13: 19-26
9. Grazzini G, Visioli CB, Zorzi M, Ciatto S, Banovich F, Bonanomi AG, Bortoli A, Castiglione G, Cazzola L, Confortini M, Mantellini P, Rubeca T, Zappa M (2009) Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening? Br J Cancer 100: 259-265
10. Guittet L, Bouvier V, Mariotte N, Vallee JP, Arsene D, Boutreux S, Tichet J, Launoy G (2007) Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut 56: 210-214
11. Hundt S, Haug U, Brenner H (2009) Comparative evaluation of immuno-chemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med 150: 162-169
12. Itoh M, Takahashi K, Nishida H, Sakagami K, Okubo T (1996) Estimation of the optimal cut off point in a new immunological faecal occult blood test in a corporate colorectal cancer screening programme. J Med Screen 3: 66-71
13. Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, Birkenfeld S, Leshno M, Niv Y (2007) A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 146: 244-255
14. Manus B, Adang RP, Ambergen AW, Bragelmann R, Armbrecht U, Stockbrugger RW (1997) The risk factor profile of recto-sigmoid adenomas: a prospective screening study of 665 patients in a clinical rehabilitation centre. Eur J Cancer Prev 6: 38-43
15. Minami Y, Nishino Y, Tsubono Y, Tsuji I, Hisamichi S (2006) Increase of colon and rectal cancer incidence rates in Japan: trends in incidence rates in Miyagi Prefecture, 1959-1997. J Epidemiol 16: 240-248
16. O'Connell JB, Maggard MA, Ko CY (2004) Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 96: 1420-1425
17. Regula J, Rupinski M, Kraszewska E, Polkowski M, Pachlewski J, Orlowska J, Nowacki MP, Butruk E (2006) Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. New Engl J Med 355: 1863-1872
18. Rubeca T, Rapi S, Confortini M, Brogioni M, Grazzini G, Zappa M, Puliti D, Castiglione G, Ciatto S (2006) Evaluation of diagnostic accuracy of screening by fecal occult blood testing (FOBT). Comparison of FOB Gold and OC Sensor assays in a consecutive prospective screening series. Int J Biol Markers 21: 157-161
19. Schlemper RJ, Riddell RH, Kato Y, Borchard F, Cooper HS, Dawsey SM, Dixon MF, Fenoglio-Preiser CM, Flejou JF, Geboes K, Hattori T, Hirota T, Itabashi M, Iwafuchi M, Iwashita A, Kim YI, Kirchner T, Klimpfinger M, Koike M, Lauwers GY, Lewin KJ, Oberhuber G, Offner F, Price AB, Rubio CA, Shimizu M, Shimoda T, Sipponen P, Solcia E, Stolte M, Watanabe H, Yamabe H (2000) The Vienna classification of gastrointestinal epithelial neoplasia. Gut 47: 251-255
20. Sedjo RL, Byers T, Levin TR, Haffner SM, Saad MF, Tooze JA, D'Agostino Jr RB (2007) Change in body size and the risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 16: 526-531
21. Segnan N, Senore C, Andreoni B, Azzoni A, Bisanti L, Cardelli A, Castiglione G, Crosta C, Ederle A, Fantin A, Ferrari A, Fracchia M, Ferrero F, Gasperoni S, Recchia S, Risio M, Rubeca T, Saracco G, Zappa M (2007) Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology 132: 2304-2312
22. Sohn DK, Jeong SY, Choi HS, Lim S, Huh JM, Kim DH, Kim YH, Chang HJ, Jung KH, Ahn JB, Kim HK, Park JG (2005) Single immunochemical fecal occult blood test for detection of colorectal neoplasia. Cancer Res Treat 37: 20-23
23. Van Rossum LG, Van Rijn AF, Laheij RJ, Van Oijen MG, Fockens P, Van Krieken HH, Verbeek AL, Jansen JB, Dekker E (2008) Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 135: 82-90
24. Vilkin A, Rozen P, Levi Z, Waked A, Maoz E, Birkenfeld S, Niv Y (2005) Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test. Am J Gastroenterol 100: 2519-2525